Abstract
Eight monomeric congeners, related to the multitarget lead candidate memoquin, were prepared and evaluated at multiple targets to determine their profile against Alzheimer's disease. 2-4 bind to AChE with similar low nanomolar affinities and function as effective inhibitors of amyloid aggregation. The most potent monovalent ligand 2 also inhibits BACE-1 in vitro and APP metabolism in primary chicken telencephalic neurons. (Figure presented)
Original language | English |
---|---|
Pages (from-to) | 8299-8304 |
Number of pages | 6 |
Journal | Journal of Medicinal Chemistry |
Volume | 54 |
Issue number | 24 |
DOIs | |
Publication status | Published - 22 Dec 2011 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery